Proteomic Analysis of Peritoneal Dialysate Fluid in Patients with Different Types of Peritoneal Membranes

Abstract

Efficacy of peritoneal dialysis is determined by solute transport through peritoneal membranes. With the use of the peritoneal equilibration test (PET), peritoneal membranes can be classified as high (H), high average (HA), low average (LA), and low (L) transporters, based on the removal or transport rate of solutes, which are small molecules. Whether there is any difference in macromolecules (i.e., proteins) removed by different types of peritoneal membranes remains unclear. We performed a gel-based differential proteomics study of peritoneal dialysate effluents (PDE) obtained from chronic peritoneal dialysis (CPD) patients with H, HA, LA, and L transport rates (n = 5 for each group; total n = 20). Quantitative analysis and ANOVA with Tukey's posthoc multiple comparisons revealed five proteins whose abundance in PDE significantly differed among groups. These proteins were successfully identified by matrix-assisted laser desorption ionization quadrupole time-of-flight (MALDI-Q-TOF) mass spectrometry (MS) and tandem mass spectrometry (MS/MS) analyses, including serum albumin in a complex with myristic acid and triiodobenzoic acid, α1-antitrypsin, complement component C4A, immunoglobulin κ light chain, and apolipoprotein A-I. The differences among groups in PDE levels of C4A and immunoglobulin κ were clearly confirmed in a validation set of the other 24 patients (n = 6 for each group) using ELISA. These data may lead to better understanding of the physiology of peritoneal membrane transport in CPD patients. Extending the study to a larger number of patients with subgroup analyses may yield additional information of the peritoneal dialysate proteins in association with dialysis adequacy, residual renal function, nutritional status, and risk of peritoneal infection. Keywords: dialysate • kidney • membranes • peritoneal dialysis • proteome • renal failure • solute clearance

Impact of uremic environment on peritoneum: A proteomic view

“…Proteomic tools, such as two-dimensional gel electrophoresis (2-DE) and mass spectrometry, have been widely applied in the study of body fluids, including cerebrospinal fluid [12], pleural and pericardial effusions [13][14][15], urine [16][17][18], and peritoneal dialysate [19][20][21]. For peritoneal fluid analysis, previous studies focus on proteome changes in endometriosis and ovarian cancer.…”

Combinatorial Peptide Ligand Library and two dimensional electrophoresis: New frontiers in the study of peritoneal dialysis effluent in pediatric patients

“…Proteomic general analysis of peritoneal effluent has been already reported to give interesting results which can have useful application in the care of patients treated with PD [23][24][25]. However, in body fluid proteomics one of the main problems is represented by the very huge dynamic range of proteins, which can be as high as 10 10 or more in serum and plasma.…”

Searching for New Biomarkers of Renal Diseases through Proteomics

“…In patients undergoing peritoneal dialysis, it is unclear whether the difference in peritoneal membrane transport characteristics is associated with different proteins cleared. This question was addressed by comparing dialysis effluent among different transporters (95 ). Twodimensional PAGE coupled to MALDI-TOF-MS and MS/MS were employed.…”